Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Afc-HD AMS Life Science Co., Ltd. (2927:JPX), powered by AI.
Afc-HD AMS Life Science Co., Ltd. is currently trading at ¥883. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Afc-HD AMS Life Science Co., Ltd. on Alpha Lenz.
View Afc-HD AMS Life Science Co., Ltd.'s valuation metrics on Alpha Lenz.
“Afc-HD AMS Life Science Co., Ltd.'s ROE is 10.0%. Explore profitability and growth together.”
Ask for details →Afc-HD AMS Life Science Co., Ltd. operates as a health and dietary supplement company in Japan. The company's primary function is the development, production, and marketing of a diverse array of nutraceutical and health-related products aimed at enhancing well-being. With a focus on quality and safety, Afc-HD AMS Life Science collaborates with academic institutions and leverages advanced technologies to innovate in the health science sector. It services a broad consumer base through direct sales, retail, and digital platforms, providing supplements that cater to various health needs such as immune support, beauty enhancement, and lifestyle diseases. As part of the broader healthcare and personal care industry, the company plays a significant role in promoting preventive health and wellness trends. Positioned in the dynamic and growing market of health supplements, it contributes to the increasing global emphasis on health maintenance and an active lifestyle.
“Afc-HD AMS Life Science Co., Ltd.'s ROE is 10.0%. Explore profitability and growth together.”
Ask for details →Afc-HD AMS Life Science Co., Ltd. (ticker: 2927) is a company listed on JPX in the Consumer Defensive sector (Packaged Foods). It has approximately 994 employees.
The current price is 883 with a P/E ratio of -x and P/B of -x.
ROE is 9.99% and operating margin is 7.38%. Annual revenue is $32.7B.